QUEST DIAGNOSTICS INC DGX
QUEST DIAGNOSTICS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.0B | $9.9B | $9.3B | $9.9B | $10.8B | $9.4B | $7.7B | $7.5B | $7.4B | $7.2B |
| Gross profit | — | — | — | — | — | $3.6B | $2.7B | $2.6B | $2.7B | $2.9B |
| SG&A expense | $2.0B | $1.8B | $1.6B | $1.9B | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | $1.4B |
| Operating income | $1.6B | $1.3B | $1.3B | $1.4B | $2.4B | $2.0B | $1.2B | $1.1B | $1.2B | $1.3B |
| Interest expense | — | — | $163.0M | $148.0M | $152.0M | $166.0M | $180.0M | $169.0M | $153.0M | $144.0M |
| Income tax | $314.0M | $273.0M | $248.0M | $264.0M | $597.0M | $460.0M | $247.0M | $182.0M | $241.0M | $429.0M |
| Net income | $992.0M | $871.0M | $854.0M | $946.0M | $2.0B | $1.4B | $858.0M | $736.0M | $772.0M | $645.0M |
| EPS (diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 |
| Operating cash flow | $1.9B | $1.3B | $1.3B | $1.7B | $2.2B | $2.0B | $1.2B | $1.2B | $1.2B | $1.1B |
| Free cash flow | $1.4B | $909.0M | $864.0M | $1.3B | $1.8B | $1.6B | $843.0M | $817.0M | $923.0M | $823.0M |
| Cash & equivalents | $420.0M | $549.0M | $686.0M | $315.0M | $872.0M | $1.2B | $1.2B | $135.0M | $137.0M | $359.0M |
| Inventory | $189.0M | $188.0M | $190.0M | $192.0M | $208.0M | $223.0M | $123.0M | $99.0M | $95.0M | $82.0M |
| Total assets | $16.2B | $16.2B | $14.0B | $12.8B | $13.6B | $14.0B | $12.8B | $11.0B | $10.5B | $10.1B |
| Shareholders' equity | $7.2B | $6.8B | $6.3B | $5.9B | $6.5B | $6.8B | $5.7B | $5.3B | $5.0B | $4.7B |
Growth · year-over-year · Revenue CAGR 4.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.8% | +6.7% | -6.4% | -8.4% | +14.3% | +22.1% | +2.6% | +1.7% | +2.6% | -3.7% |
| Net income growth | +13.9% | +2.0% | -9.7% | -52.6% | +39.4% | +66.8% | +16.6% | -4.7% | +19.7% | -9.0% |
| EPS growth | +13.8% | +2.7% | -6.0% | -48.7% | +48.5% | +66.7% | +18.7% | -3.8% | +22.0% | -7.4% |
| Free cash flow growth | +49.5% | +5.2% | -34.2% | -28.2% | +15.3% | +88.3% | +3.2% | -11.5% | +12.2% | +47.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.